Alzheimer’s progress slowed by plaque-busting drug

A clinical trial has shown that the drug aducanumab slows cognitive decline in people with Alzheimer’s and reduces the amount of amyloid plaque in their brain
—> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail